Who Owns Quality?

June 27, 2014

When it comes to the Healthcare industry (e.g. pharmaceuticals, medical devices, dietary supplements, etc.) who owns a company’s Quality Assurance practices? Without a doubt the Quality organization has had the burden, if you will, for their business’s quality practices. And Quality Assurance (QA) has its hands full “Assuring” that they continue to change to meet the on-going challenges before them. Here are a few challenges that QA is up against:

Mindsets throughout the organization

  •  Changing from a “they” to a “we” approach of ownership of quality
  •  Changing from a problem-solver to a preventer approach of investigations
  •  Changing from an enforcer to an advocate approach of practices
  •  Changing from a results to a purpose driven approach of orientation
  •  Changing from a conformity to a continuous improvement approach of inspections

Respect throughout the organization

Spending much of my professional career in quality, this one hits home. In my experience, QA has been the point group of Subject Matter Experts (SME) within the pharmaceutical industry for making tough, sound, quality decisions, and they should. With that being said, QA is challenged with the ever-changing pursuit of mutual respect within the company between departments. As regulatory requirements and the manufacturing processes adjust, Quality must be able to adjust as well to keep pace. QA needs to equip themselves with the necessary quality expertise to fully understand and be engaged in the manufacturing processes and the problems that arise. QA must be seen as agents of collaboration, innovation and a trusted team player among all departments.

Robust quality systems throughout the organization

Finally, QA can implement more robust quality systems or processes that envelope manufacturing. Although QA has no direct control in the design of the manufacturing process, it does have systematic control over the systems that support manufacturing. Such systems include change control, document control, investigations, training, auditing, and validation. Designing, building and maintaining a robust quality system ensures a state of control throughout the entire product lifecycle and is as important as the product itself.

Performing periodic assessments of the company’s quality systems is a critical function of QA to ensure robustness. A typical process assessment evaluates:

  •  Whether the system is performing as designed to prevent or mitigate errors;
  •  Whether there is a dedicated person who “owns” the management, evaluation and improvement of the system;
  •  Whether the system is an integral part of a unified, larger system;
  •  Whether metrics are clearly defined, utilized and drive each independent part of the system to achieve the desired outcome

The Quality organization that sees the challenges set before them associated with employee mindsets, respect and system robustness and meets those challenges head on, will be the one that is a leader in their company and the entire industry.

So “who owns Quality?” Without a doubt, everyone owns quality. Every company employee from the technician on the manufacturing floor, to the process engineer and the site head are responsible for the quality of every aspect of their job. And certainly as their namesake, the Quality organization has the chief role of proactively leading the team with collaboration, enhanced systems and management controls.

Reference:
June 2014 PDA Letter “Today’s challenges for QA personnel” Robert Kieffer


Learn more about ProPharma Group's Compliance services.
Contact us to get in touch with our subject matter experts for a customized Compliance presentation
.

 




Quality & Compliance GMP

June 27, 2014

Outsourcing Functions Doesn't Mean You've Outsourced Compliance Obligations

Over the past 20 years, the traditional approach to drug development has expanded to include the outsourcing of a range of testing and manufacturing functions. As a part of their long-term strategic...

Read More
FDA North America

June 27, 2014

FDA Issues FY2021 Report on the State of Pharmaceutical Quality

FDA Issues FY2021 Report on the State of Pharmaceutical Quality: The Office of Pharmaceutical Quality (OPQ) within FDA’s Center for Drug Evaluation and Research has published the fiscal year 2021...

Read More
Supplier Management Life Science Consulting

June 27, 2014

5 Steps for Developing and Managing Supplier Quality Programs

With the increased pressures of cost control for manufacturers of FDA-regulated products and the rapid expansion of globalization of the supply chain, the expectations of manufacturers and sponsors...

Read More